Martin Lynch, MD
Undersea and Hyperbaric Medicine · Rome, GANPI 1194887026
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $160 and has fallen 80.6% since, to $31 in 2024.
Across 22 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aroa Biosurgery Incorporated$100
- Polymedics Innovations Inc.$96
- Smith+Nephew$95
- Organogenesis Inc.$33
- Melinta Therapeutics, LLC$21
- KCI USA, Inc.$20
- plus $55 from 4 others
What the payments were for
- Food & beverage$419100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aroa Biosurgery Incorporated | 5 | $100 |
| Polymedics Innovations Inc. | 3 | $96 |
| Smith+Nephew | 6 | $95 |
| Organogenesis Inc. | 2 | $33 |
| Melinta Therapeutics, LLC | 1 | $21 |
| KCI USA, Inc. | 1 | $20 |
| Hydrofera LLC | 1 | $16 |
| AbbVie | 1 | $14 |
| Molnlycke Health Care US, LLC | 1 | $13 |
| Medline Industries LP | 1 | $12 |
How this compares
Too few undersea and hyperbaric medicine providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clindamycin Hcl | 109 | $1,025 |
| Fluconazole | 17 | $222 |
| Ciprofloxacin Hcl | 28 | $197 |
| Doxycycline Monohydrate | 20 | $180 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $167 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $107 |
| Furosemide | 14 | $39 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Rome
- Belinda MarcusNewnan$26K
- Dana ConnerBlairsville$4K
- Norman McCullochWinder$2K
- Ricardo DuranRoswell$2K
- William LagalyAthens$2K
- Jose GomezCalhoun$1K
- Daniel BelessSandy Springs$955
- John SpenceVidalia$569
- John McGlynnMarietta$456
- Helen GellyMarietta$439
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.